Howe & Rusling Inc Sanofi Transaction History

Howe & Rusling Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$48.99 - $57.46 $2,743 - $3,217	-56 Reduced 12.36%	397 $20,000
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $2,118 - $2,355	45 Added 11.03%	453 $23,000
Q2 2021 Aug 13, 2021	BUY	$49.36 - $54.25 $7,305 - $8,029	148 Added 56.92%	408 $21,000
Q1 2021 May 13, 2021	SELL	$45.46 - $50.51 $3,091 - $3,434	-68 Reduced 20.73%	260 $13,000
Q2 2020 Jul 15, 2020	BUY	$42.91 - $52.5 $3,432 - $4,200	80 Added 32.26%	328 $17,000
Q1 2020 May 14, 2020	BUY	$38.02 - $51.66 $9,428 - $12,811	248 New	248 $11,000
Q2 2019 Aug 12, 2019	SELL	$40.43 - $44.3 $34,769 - $38,098	-860 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$40.83 - $45.43 $35,113 - $39,069	860 New	860 $38,000

807

270M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $134B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

Stay updated on Howe & Rusling Inc with notifications on news.